Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ S=`+Ryc
<A5
]]{9 +
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© }x0- V8
/u%h8!"R
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© ulFzZHJ
YgUH'P-
1.Co-stimulators (or co-stimulating molecules) #oeG!<Mn
h%; e0Xz|
2.NK-kB fWc|gq
=J-5.0Q\_\
3.Immunoglobulin superfamily 7hW+T7u?
:<Y}l-x
4.antigen-presenting cell (APC) .nu @ o40
fKC3-zm
5.death domain >(w2GD?
PNF?;*`-{7
6.CCR and CXCR D\w h;r
`@d<n
7.Lectin (or mitogen) uwf
5!Z:>
E!BPE>
8.Clusters of differentiation, CD) Aa0b6?Jm
EN{]Qb06A
9.B7 family TD[EQ
|7,L`utp
10.Cytotoxic T lymphocyte, CTL) sDr/k`>
}+o:j'jB
11.IL-15 and IL-15 receptor (IL-15R) k#8Ti"0
HEL!GC>#
12.MHC restriction iGB_{F~t4}
v_e9}yI
13.Affinity-chromatography [7(-T?_
1im^17X
14.Cyctosprin A, CsA 43?^7_l-
Qk!;M|
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ]E =Iu
XwV'Ha
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 4Mk-2 Dx
5es[Ph|K5
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ^pn(=4
b:qY gg
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ eC5 $#,HiC
tm7u^9]
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ r{L4]|(utY
iU6Gp-<M,
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© Fnk_\d6Ma
`eu9dLzH
ÃâÒßѧרҵ£º Y#!h9F
.]aF
1}AI
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Sa19q.~%
$gBd <N9|c
Ïû»¯ÄÚ¿Æ£º (98Nzgxgx}
''\;z<v
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ]*7Y~dO
<b/~.$a'
ѪҺ²¡Ñ§×¨Òµ£º s1?[7yC
wP,JjPUt
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿